BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26758534)

  • 41. Effect of proline rich domain of an RNA-binding protein Sam68 in cell growth process, death and B cell signal transduction.
    Li QH; Fan TX; Pang TX; Yuan WS; Han ZC
    Chin Med J (Engl); 2006 Sep; 119(18):1536-42. PubMed ID: 16996007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous neoplasms showing EWSR1 rearrangement.
    Boland JM; Folpe AL
    Adv Anat Pathol; 2013 Mar; 20(2):75-85. PubMed ID: 23399793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO.
    Wichmann C; Grez M; Lausen J
    Curr Drug Targets; 2010 Sep; 11(9):1181-91. PubMed ID: 20583973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Progress of study on relationship between Mcl-1 gene and hematologic malignancies - review].
    Li ZH; Li HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):509-12. PubMed ID: 19379600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cellular targets of antitumor ribonucleases].
    Mit'kevich VA; Makarov AA; Il'inskaia ON
    Mol Biol (Mosk); 2014; 48(2):214-22. PubMed ID: 25850290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosomal aberrations and fusion genes in myeloid malignancies.
    Gianfelici V; Lahortiga I; Cools J
    Expert Rev Hematol; 2012 Aug; 5(4):381-93. PubMed ID: 22992233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
    Sun H; Lin DC; Cao Q; Guo X; Marijon H; Zhao Z; Gery S; Xu L; Yang H; Pang B; Lee VK; Lim HJ; Doan N; Said JW; Chu P; Mayakonda A; Thomas T; Forscher C; Baloglu E; Shacham S; Rajalingam R; Koeffler HP
    Cancer Res; 2016 May; 76(9):2687-97. PubMed ID: 26956669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.
    Lu X; Zhuang H; Yu Q; Zhang X; Wu Z; Zhang L; Xu Y; Wu B; Yang L; Ma A; Gan X; Yu X; Shen J; Xu R
    Exp Cell Res; 2018 Oct; 371(2):409-416. PubMed ID: 30179602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tyrosine receptor kinase B is a drug target in astrocytomas.
    Ni J; Xie S; Ramkissoon SH; Luu V; Sun Y; Bandopadhayay P; Beroukhim R; Roberts TM; Stiles CD; Segal RA; Ligon KL; Hahn WC; Zhao JJ
    Neuro Oncol; 2017 Jan; 19(1):22-30. PubMed ID: 27402815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
    Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
    Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6.
    Ojala PM; Tiainen M; Salven P; Veikkola T; Castaños-Vélez E; Sarid R; Biberfeld P; Mäkelä TP
    Cancer Res; 1999 Oct; 59(19):4984-9. PubMed ID: 10519412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further research on the activity of ribonucleases in the blood and urine of patients suffering from proliferative hemocytopathia.
    ALEKSANDROWICZ J; URBANCZYK J; OSTROWSKA A; SIERKO J
    Blood; 1958 Jul; 13(7):652-64. PubMed ID: 13560564
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute Myeloid Leukemia With
    Nakano Y; Yamasaki K; Otsuka Y; Ujiro A; Kawakita R; Tamagawa N; Okada K; Fujisaki H; Yorifuji T; Hara J
    Glob Pediatr Health; 2017; 4():2333794X16689011. PubMed ID: 28239626
    [No Abstract]   [Full Text] [Related]  

  • 56. Progress in Diseases of the Blood.
    Hospital (Lond 1886); 1902 May; 32(814):83-84. PubMed ID: 29838107
    [No Abstract]   [Full Text] [Related]  

  • 57. Progress in Diseases of the Blood.
    Hospital (Lond 1886); 1901 Dec; 31(794):186-187. PubMed ID: 29819404
    [No Abstract]   [Full Text] [Related]  

  • 58. Progress in Diseases of the Blood.
    Hospital (Lond 1886); 1901 Nov; 31(791):134-135. PubMed ID: 29819381
    [No Abstract]   [Full Text] [Related]  

  • 59. Progress in Diseases of the Blood.
    Hospital (Lond 1886); 1902 Dec; 33(846):179-180. PubMed ID: 29818626
    [No Abstract]   [Full Text] [Related]  

  • 60. Progress in Diseases of the Blood.
    Hospital (Lond 1886); 1902 Nov; 33(841):95-96. PubMed ID: 29818409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.